JP2004509617A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004509617A5 JP2004509617A5 JP2002525188A JP2002525188A JP2004509617A5 JP 2004509617 A5 JP2004509617 A5 JP 2004509617A5 JP 2002525188 A JP2002525188 A JP 2002525188A JP 2002525188 A JP2002525188 A JP 2002525188A JP 2004509617 A5 JP2004509617 A5 JP 2004509617A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleic acid
- seq
- cells
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920001184 polypeptide Polymers 0.000 description 28
- 108090000765 processed proteins & peptides Proteins 0.000 description 28
- 102000004196 processed proteins & peptides Human genes 0.000 description 28
- 108020004707 nucleic acids Proteins 0.000 description 22
- 102000039446 nucleic acids Human genes 0.000 description 22
- 150000007523 nucleic acids Chemical class 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 241000288906 Primates Species 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 230000000890 antigenic effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000002029 Claudin Human genes 0.000 description 1
- 108050009302 Claudin Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Images
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23126700P | 2000-09-08 | 2000-09-08 | |
| PCT/US2001/028013 WO2002020569A2 (en) | 2000-09-08 | 2001-09-07 | Mammalian genes; related reagents and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008218815A Division JP2009039124A (ja) | 2000-09-08 | 2008-08-27 | 哺乳動物遺伝子；関連試薬および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004509617A JP2004509617A (ja) | 2004-04-02 |
| JP2004509617A5 true JP2004509617A5 (enExample) | 2008-10-16 |
Family
ID=22868480
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002525188A Withdrawn JP2004509617A (ja) | 2000-09-08 | 2001-09-07 | 哺乳動物遺伝子；関連試薬および方法 |
| JP2008218815A Withdrawn JP2009039124A (ja) | 2000-09-08 | 2008-08-27 | 哺乳動物遺伝子；関連試薬および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008218815A Withdrawn JP2009039124A (ja) | 2000-09-08 | 2008-08-27 | 哺乳動物遺伝子；関連試薬および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (6) | US7060800B2 (enExample) |
| EP (2) | EP1315743B1 (enExample) |
| JP (2) | JP2004509617A (enExample) |
| CN (1) | CN1452633A (enExample) |
| AT (1) | ATE549347T1 (enExample) |
| AU (1) | AU2001294541A1 (enExample) |
| CA (1) | CA2419979A1 (enExample) |
| MX (1) | MXPA03002049A (enExample) |
| WO (1) | WO2002020569A2 (enExample) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1235845A4 (en) * | 1999-11-05 | 2003-06-25 | Human Genome Sciences Inc | 24 HUMAN SECRETED PROTEINS |
| AU2253301A (en) | 1999-12-03 | 2001-06-12 | Zymogenetics Inc. | Human cytokine receptor |
| US20030170823A1 (en) | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
| EP1337636B1 (en) | 2000-08-08 | 2006-10-18 | ZymoGenetics, Inc. | Soluble zcytor 11 cytokine receptors |
| US7358353B2 (en) * | 2000-08-22 | 2008-04-15 | Agensys, Inc. | Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| US20030166526A1 (en) | 2000-08-22 | 2003-09-04 | Challita-Eid Pia M. | Nucleic acid and corresponding protein named 158P1H4 useful in the treatment and detection of bladder and other cancers |
| WO2002020569A2 (en) * | 2000-09-08 | 2002-03-14 | Schering Corporation | Mammalian genes; related reagents and methods |
| DK1356046T3 (da) * | 2000-11-28 | 2010-03-01 | Zymogenetics L L C | Cytokinreceptor zcytoR19 |
| CA2430257A1 (en) * | 2000-11-28 | 2002-06-06 | Amgen, Inc. | Transforming growth factor-beta-related molecules and uses thereof |
| AU2002252460A1 (en) | 2001-03-27 | 2002-10-08 | Zymogenetics, Inc. | Human cytokine receptor |
| US7038032B2 (en) | 2001-04-20 | 2006-05-02 | Zymogenetics, Inc. | Cytokine protein family |
| US7910313B2 (en) | 2001-04-20 | 2011-03-22 | Zymogenetics, Inc. | Cytokine protein family |
| WO2003031620A1 (en) * | 2001-10-02 | 2003-04-17 | Mochida Pharmaceutical Co., Ltd. | Novel class ii cytokine receptor |
| US7033787B2 (en) * | 2001-12-21 | 2006-04-25 | Ludwig Institute For Cancer Research | Isolated cytokine receptor LICR-2 |
| US7265211B2 (en) | 2002-03-22 | 2007-09-04 | Zymogenetics, Inc. | Anti-IL-TIF antibodies and methods of making |
| EP1497415B1 (en) | 2002-04-19 | 2010-12-29 | ZymoGenetics, L.L.C. | Methods for detection or modulation of the interaction of a cytokine receptor with its ligand |
| US7141381B2 (en) | 2002-04-25 | 2006-11-28 | Bristol-Myers Squibb Company | Human leucine-rich repeat-containing proteins specifically expressed in the nervous system |
| PT1941867E (pt) | 2002-06-07 | 2012-02-16 | Dyax Corp | Polipeptídeo contendo um domínio kunitz modificado |
| EP1575609A4 (en) | 2002-10-23 | 2010-12-15 | Zymogenetics L L C | METHOD FOR THE TREATMENT OF VIRUS INFECTIONS USING IL-28 AND IL-29 |
| DE10254601A1 (de) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| EP1594892A2 (en) * | 2003-02-10 | 2005-11-16 | Agensys, Inc. | Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| KR20050116392A (ko) | 2003-03-24 | 2005-12-12 | 지모제넥틱스, 인코포레이티드 | 항-ｉｌ-22ｒａ 항체 및 결합 파트너 및 염증에 있어서의사용 방법 |
| WO2005023862A2 (en) | 2003-08-07 | 2005-03-17 | Zymogenetics, Inc. | Homogeneous preparations of il-28 and il-29 |
| PT1663281E (pt) * | 2003-08-29 | 2014-03-17 | Dyax Corp | Inibidores de proteases poli-peguilados |
| GB0325038D0 (en) * | 2003-10-27 | 2003-12-03 | Ares Trading Sa | Protein |
| US20050244423A1 (en) | 2004-04-02 | 2005-11-03 | Klucher Kevin M | Methods for treating viral infection using IL-28 and IL-29 cysteine mutants |
| DE102004024617A1 (de) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
| WO2006012644A2 (en) | 2004-07-29 | 2006-02-02 | Zymogenetics, Inc. | Use of il-28 and il-29 to treat cancer |
| US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| BRPI0516975A (pt) | 2004-10-22 | 2008-09-30 | Zymogenetics Inc | anticorpo ou seu fragmento de ligação a antìgeno, composição farmacêutica, imunoconjugado, hibridoma, anticorpo monoclonal, e, uso de um anticorpo ou seu fragmento de ligação a antìgeno |
| GB0423973D0 (en) * | 2004-10-28 | 2004-12-01 | Ares Trading Sa | C1q related points |
| CA2603671C (en) * | 2005-04-26 | 2012-03-27 | Laboratoires Serono S.A. | Insp163 polypeptides for the treatment or prevention of cancer and arthritis |
| JP4987001B2 (ja) | 2005-07-20 | 2012-07-25 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | 癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法 |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| US20090182035A1 (en) * | 2007-04-11 | 2009-07-16 | Alcon Research, Ltd. | Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |
| CN101641094A (zh) * | 2007-04-11 | 2010-02-03 | 爱尔康研究有限公司 | TNFα抑制剂联合抗组胺药治疗变应性鼻炎和变应性结膜炎的用途 |
| DK2915564T3 (da) | 2007-09-28 | 2021-02-08 | Alexion Pharma Inc | Antidoter mod faktor XA-inhibitorer og fremgangsmåder til anvendelse deraf |
| PL3604510T3 (pl) | 2009-03-30 | 2025-07-28 | Alexion Pharmaceuticals, Inc. | Antidota na inhibitory czynnika xa i sposoby ich stosowania |
| CN102625712B (zh) | 2009-07-15 | 2017-07-25 | 博尔托拉制药公司 | 用于因子xa抑制剂的解毒剂的单位剂量制剂及其使用方法 |
| BR112012007091A2 (pt) * | 2009-10-01 | 2016-04-19 | Alcon Res Ltd | composições de olopatadina e seus usos |
| WO2013016449A2 (en) | 2011-07-26 | 2013-01-31 | Indicator Systems International, Inc. | Assays for the detection of microbes |
| KR102143887B1 (ko) | 2012-03-16 | 2020-08-12 | 유니버시티 헬스 네트워크 | Toso 활성을 조절하기 위한 방법 및 조성물 |
| WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
| WO2013174404A1 (en) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| KR102355959B1 (ko) | 2012-08-23 | 2022-01-27 | 어젠시스 인코포레이티드 | 158p1d7 단백질에 결합하는 항체 약물 컨쥬게이트(ａｄｃ) |
| US10093736B2 (en) | 2012-11-13 | 2018-10-09 | Biontech Ag | Agents for treatment of claudin expressing cancer diseases |
| WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| WO2014146672A1 (en) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Therapy involving antibodies against claudin 18.2 for treatment of cancer |
| AU2015225867B2 (en) | 2014-03-07 | 2020-02-06 | University Health Network | Methods and compositions for modifying the immune response |
| KR102555955B1 (ko) | 2014-03-27 | 2023-07-18 | 다케다 파머수티컬 컴패니 리미티드 | 당뇨병성 황반 부종의 치료를 위한 조성물 및 방법 |
| WO2017011275A1 (en) | 2015-07-10 | 2017-01-19 | Nersissian Aram M | Factor viii protein compositions and methods of treating hemophilia a |
| HK1255383A1 (zh) | 2015-07-31 | 2019-08-16 | The Research Institute At Nationwide Children's Hospital | 去除生物膜的肽及抗體 |
| EP3365027B1 (en) | 2015-10-14 | 2022-03-30 | Research Institute at Nationwide Children's Hospital | Hu specific antibodies and their use in inhibiting biofilm |
| AU2018206552C1 (en) | 2017-01-04 | 2025-04-10 | Research Institute At Nationwide Children's Hospital | DNABII vaccines and antibodies with enhanced activity |
| EP3565834B1 (en) | 2017-01-04 | 2025-10-22 | The Research Institute at Nationwide Children's Hospital | Antibody fragments for the treatment of biofilm-related disorders |
| US11746136B2 (en) | 2017-03-15 | 2023-09-05 | Research Institute At Nationwide Children's Hospital | Composition and methods for disruption of bacterial biofilms without accompanying inflammation |
| CN110229226B (zh) * | 2019-05-23 | 2023-04-11 | 西安医学院 | 一种slfn11截断肽及其应用和药物组合物 |
| US12209118B2 (en) | 2019-07-08 | 2025-01-28 | Research Institute At Nationwide Children's Hospital | Antibody compositions for disrupting biofilms |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US88426A (en) | 1869-03-30 | Improved velocipede | ||
| US2736896A (en) | 1951-12-04 | 1956-02-28 | Sperry Rand Corp | Horn antenna system |
| US3645090A (en) | 1969-06-19 | 1972-02-29 | Citizen Watch Co Ltd | Day-date quick-adjuster for calender timepiece |
| US3940475A (en) | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4659678A (en) | 1982-09-29 | 1987-04-21 | Serono Diagnostics Limited | Immunoassay of antigens |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4859609A (en) | 1986-04-30 | 1989-08-22 | Genentech, Inc. | Novel receptors for efficient determination of ligands and their antagonists or agonists |
| US6277969B1 (en) * | 1991-03-18 | 2001-08-21 | New York University | Anti-TNF antibodies and peptides of human tumor necrosis factor |
| US6270989B1 (en) | 1991-11-05 | 2001-08-07 | Transkaryotic Therapies, Inc. | Protein production and delivery |
| WO2002020569A2 (en) * | 2000-09-08 | 2002-03-14 | Schering Corporation | Mammalian genes; related reagents and methods |
| US11068393B2 (en) | 2019-10-17 | 2021-07-20 | Microsoft Technology Licensing, Llc | Enhanced concurrency garbage collection stack scanning |
-
2001
- 2001-09-07 WO PCT/US2001/028013 patent/WO2002020569A2/en not_active Ceased
- 2001-09-07 EP EP01975188A patent/EP1315743B1/en not_active Expired - Lifetime
- 2001-09-07 JP JP2002525188A patent/JP2004509617A/ja not_active Withdrawn
- 2001-09-07 EP EP10179792A patent/EP2298789B1/en not_active Expired - Lifetime
- 2001-09-07 MX MXPA03002049A patent/MXPA03002049A/es unknown
- 2001-09-07 CA CA002419979A patent/CA2419979A1/en not_active Abandoned
- 2001-09-07 CN CN01815161A patent/CN1452633A/zh active Pending
- 2001-09-07 US US09/949,192 patent/US7060800B2/en not_active Expired - Fee Related
- 2001-09-07 AT AT10179792T patent/ATE549347T1/de active
- 2001-09-07 AU AU2001294541A patent/AU2001294541A1/en not_active Abandoned
-
2005
- 2005-03-25 US US11/090,448 patent/US7427668B2/en not_active Expired - Fee Related
-
2008
- 2008-08-27 JP JP2008218815A patent/JP2009039124A/ja not_active Withdrawn
- 2008-09-22 US US12/235,404 patent/US7696317B2/en not_active Expired - Fee Related
-
2009
- 2009-12-22 US US12/644,404 patent/US7893211B2/en not_active Expired - Fee Related
-
2010
- 2010-12-21 US US12/974,559 patent/US8148507B2/en not_active Expired - Fee Related
-
2012
- 2012-03-07 US US13/414,496 patent/US8426573B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004509617A5 (enExample) | ||
| JP4089920B2 (ja) | 細菌レセプター構造体 | |
| US20040018587A1 (en) | Nanostructures containing antibody assembly units | |
| WO2003072803A2 (en) | Nanostructures containing antibody assembly units | |
| CN104804093A (zh) | 一种针对cd47的单域抗体 | |
| JPH06504446A (ja) | 肺炎球菌タンパクの構造遺伝子 | |
| JPH02295487A (ja) | キメラモノクローナル抗体の産生のための発現系 | |
| JP2003500010A5 (enExample) | ||
| JP3570737B2 (ja) | リステリア検出のための方法および試薬 | |
| JPH05509234A (ja) | ヒトＴリンパ球レセプターのα鎖の可変領域をコードするヌクレオチド配列対応するペプチドセグメント並びに診断及び治療への利用 | |
| CN115976076A (zh) | HBC-SpyTag003融合基因、其表达载体、单克隆抗体及其应用 | |
| JPH08242865A (ja) | ヒト免疫グロブリンｅ結合因子活性ポリペプチドをコードする遺伝子系 | |
| AU632513B2 (en) | Cdnas coding for the gamma subunit of the high-affinity receptor for immunoglobulin e | |
| JPH09507745A (ja) | 組換えＰｉｌＣタンパク質、それらの製造方法及び使用方法 | |
| JP4053084B2 (ja) | 血小板ＧＰＩＩＩａＰ１▲Ａ１▼およびＰ１▲Ａ２▼エピトープ、その調整並びに使用 | |
| JPS5944399A (ja) | 新規ｄｎａ | |
| CN106046165A (zh) | 抗CTLA‑4的纳米抗体Nb30及其制备方法与应用 | |
| JPH05505943A (ja) | コラーゲン結合タンパク質およびその製造方法 | |
| JP2001522605A5 (enExample) | ||
| CN113214364A (zh) | 一种多重耐药鲍曼不动杆菌识别元件的挖掘与验证 | |
| CN106928360B (zh) | 一种CD105纳米抗体Nb68 | |
| JPH05509233A (ja) | 結核菌蛋白ｍｔｐ４０のヌクレオチドおよびアミノ酸配列並びにそれに由来する合成ペプチド | |
| JP4521519B2 (ja) | 部分ヒストンテイル型イムノポーター | |
| JP2009542243A5 (enExample) | ||
| CN119978135B (zh) | Sumo标签蛋白的特异性抗体及其制备方法与应用 |